Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8903951 | 1.00 | CYP3A4 (0.46) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL29044522 | 0.97 | CYP3A4 (0.44) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL723082 | 0.90 | POLB (0.43) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL720380 | 0.86 | CYP3A4 (0.39) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL23193312 | 0.84 | CYP3A4 (0.38) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL16116448 | 0.84 | — | — | |
| SCHEMBL14277900 | 0.81 | CYP3A4 (0.39) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL8224822 | 0.80 | POLB (0.59) | CYP1A2CYP2C9POLBMAPT | |
| SCHEMBL4553513 | 0.78 | CYP3A4 (0.41) | CYP3A4CASP3CYP1A2CYP2C9POLB | |
| SCHEMBL11323340 | 0.77 | ALDH1A1 (0.42) | CYP3A4CASP3CYP1A2CYP2C9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 898 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11898106-B2 | Oil-wetting chemicals for solids retention | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-02-13 | — | — | US | claimed |
| US-20230383196-A1 | OIL-WETTING CHEMICALS FOR SOLIDS RETENTION | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2023-11-30 | — | — | US | claimed |
| CN-111217708-B | Preparation method and weeding application of alkyl perillamine derivative | 中国林业科学研究院林产化学工业研究所 | 2022-07-26 | — | — | CN | claimed |
| CN-109563431-B | Lubricating oil composition, lubricating method, and transmission | 出光兴产株式会社 | 2022-05-03 | — | — | CN | claimed |
| US-20220025735-A1 | REDUCING ASPHALTENES IN PRODUCED FLUIDS FROM A WELLBORE | CHEVRON U.S.A. INC. (US) | 2022-01-27 | — | — | US | claimed |
| US-10793802-B2 | Mixed phosphorus esters for lubricant applications | THE LUBRIZOL CORPORATION (US) | 2020-10-06 | — | — | US | claimed |
| EP-3436553-B1 | COMPATIBILIZING AND STABILIZING COMPOSITION FOR FUEL OILS AND PROCESS FOR STABILIZING SAID OILS | CHIMEC SPA (IT) | 2020-05-13 | — | — | EP | claimed |
| US-10639382-B2 | Method for treating leukemia | NATIONAL GUARD HEALTH AFFAIRS (SA) | 2020-05-05 | — | — | US | claimed |
| CN-110938479-A | Petrochemical additive and preparation method thereof | 兰州石化职业技术学院 | 2020-03-31 | — | — | CN | claimed |
| CN-110839638-A | Microemulsion containing difenoconazole and propiconazole and preparation method thereof | 惠州市银农科技股份有限公司 | 2020-02-28 | — | — | CN | claimed |
| EP-0202024-B1 | ADDITIVE FOR LUBRICATING OILS AND HYDROCARBON FUELS | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1992-06-17 | — | — | EP | claimed |
| EP-0230382-B1 | ADDITIVE FOR LUBRICATING OILS AND HYDROCARBON FUELS | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1991-11-06 | — | — | EP | claimed |
| EP-0308445-B1 | PROCESS FOR THE PREPARATION OF A SUPERALKALINIZED ADDITIVE CONTAINING AN INORGANIC BORON DERIVATIVE, ADDITIVE PRODUCED BY SAID PROCESS AND LUBRICATING COMPOSITIONS CONTAINING SAID ADDITIVE | ELF FRANCE, Société Anonyme dite: (FR) | 1991-08-28 | — | — | EP | claimed |
| CN-1011296-B | Method for separating non-sulfide ore by flotation | HENKEL KGAA (DE) | 1991-01-23 | — | — | CN | claimed |
| EP-0407124-A1 | Lubricating oil composition | Tonen Corporation (JP) | 1991-01-09 | — | — | EP | claimed |
| EP-0252242-B1 | PROCESS FOR THE MANUFACTURE OF C1 TO C6 N-ALKYL PYRROLIDONES FROM SUCCINIC-ACID ANHYDRIDE OR A C1 TO C6 N-ALKYL SUCCINIMIDE | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-11-28 | — | — | EP | claimed |
| EP-0321424-A2 | Process to increase yield in plants for thermal coversion of oils, particularly middle distillates | CHIMEC S.P.A. (IT) | 1989-06-21 | — | — | EP | claimed |
| US-4814464-A | Process for making N-alkylpyrrolidones | AMOCO CORPORATION (US) | 1989-03-21 | — | — | US | claimed |
| US-4747964-A | Dispersing additive compositions for lubricating oils and their manufacture | INSTITUT FRANCAIS DU PETROLE (FR) | 1988-05-31 | — | — | US | claimed |
| US-4011167-A | LUBRICANT COMPOSITIONS CONTAINING METAL COMPLEXES AS DETERGENTS | MOBIL OIL CORPORATION (US) | 1977-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10639382-B2 | Method for treating leukemia | ADRA2A, ADRB2, ADRA2C | CYP3A4 738/4885CASP3 1920/4885CYP1A2 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.